Abstract: Garcinielliptone FC (GFC) is a polyisoprenylated benzophenone isolated from Platonia insignis Mart (Clusiaceae) with promising anticonvulsant properties. However, its safe use and other effects on the central nervous system require assessment. This study assessed the toxicological effects of GFC using the comet assay and the micronucleus test in mice treated for 28 days. A behavioural model was employed to detect possible injuries on the central nervous system. Mice treated with GFC (2, 10 and 20 mg/kg; i.p.) daily for 28 days were submitted to rotarod test, open-field test and tail suspension test (TST). After the behaviour tasks, biological samples were assessed to evaluate genotoxic and mutagenic effects using the comet assay and the micronucleus test. Garcinielliptone FC did not impair the performance of the animals in the rotarod and open-field tests, with no antidepressant-like effect in TST. No genotoxic effects in blood and cerebral cortex were observable in the comet assay; however, there was a significant increase in index and frequency of damage in liver after treatment with GFC 20 mg/kg. Garcinielliptone FC did not increase micronucleus frequency in bone marrow. At the tested doses, GFC was not toxic to the CNS and did not induce genotoxic damage to blood or bone narrow cells. DNA damage to liver tissue was caused only by the highest dose, although no mutagenic potential was observed.
(2D) nuclear magnetic resonance (NMR) analysis [4] . All the organic extracts were concentrated to dryness under reduced pressure and temperatures below 45°C.
High-performance liquid chromatography analysis. The highperformance liquid chromatography (HPLC) method used to analyse GFC was developed based on a previously described procedure [12] . The chromatographic separation was performed using a HPLC system consisting of a Waters 2695 Alliance separation module equipped with a Waters 2487 L dual-wavelength ultraviolet (UV) detector (273 nm) and controlled by an IEEE-488 interface module. For the stationary phase, a Waters Spherisorb ODS2 reversed-phase column (250 mm 9 4.6 mm, particle diameter: 5 mm) was used. The mobile phase consisted of a mixture of acetonitrile and 0.3% v/v orthophosphoric acid (90:10, v/v). The mobile phase was adjusted to pH 2.5 with 1 N phosphoric acid, and the solution was degassed by suction filtration through a 0.45-mm membrane. The diluted extract solution was eluted isocratically using a C18 reversed-phase column and a mobile phase consisting of acetonitrile and 0.3% phosphoric acid (90:10, v/v) at a 1.5 mL/min. flow rate. Garcinielliptone FC was detected by UV (273 nm).
Animals. Male Swiss mice (2 months old, 30-40 g animals, n = 60) were obtained from the Federal University of Pelotas, RS, Brazil. The mice were housed in plastic cages (five per cage) with ad libitum access to water and food under a 12-hr light/dark cycle (light on at 8:00) and at a constant temperature of 23 AE 2°C. This work was approved by the Committee on the Ethical Use of Animals of the Federal University of Rio Grande do Sul (UFRGS, N. 22559). The animals used in this study were handled in strict accordance with guidelines and procedures prescribed by the National Council of Animal Experimentation Control (CONCEA, Brazil).
Drugs. Garcinielliptone FC was dissolved in a 5% Tween solution in sodium chloride (NaCl 0.9%, saline). Imipramine (20 mg/kg) was used as positive control in the tail suspension test (TST); it was dissolved in saline. All drugs were administered as 10 mL/kg intraperitoneal (i.p.) injections.
Subchronic treatment. Sixty mice were divided into six groups. They were treated for 28 days with single doses (0.1 mL/10 g body-weight) of GFC (2, 10 or 20 mg/kg), saline, Tween 5% or imipramine (20 mg/kg). The animals were weighed and observed daily for physiological and behavioural changes [13] .
On the 27th and 28th days, the mice were subjected to behavioural tests (rotarod, open-field and tail suspension tests). On these days, the animals received treatment after tests, not before, to prevent the detection of an acute treatment response. Samples used in the comet assay and the micronucleus test were collected after subchronic treatment.
Rotarod test. On the 27th day of treatment, the animals were submitted to the rotarod test according to Leal et al. [14] . The animals were evaluated for the ability to remain on the revolving (18 rpm) bar of the rotarod apparatus (Ugo Basile, Varese, Italy) for 90 sec., and latency to fall was recorded.
Open-field behaviour. On the 28th day of treatment, the animals were submitted to the open-field test. Mice were placed in a 40 9 50 9 60 cm open-field set divided into 12 equal squares as a grid. The animals were placed in the left rear square and allowed to explore freely for 5 min. Crossings of the black lines, rearings performed and latency to start locomotion were counted and considered indicators of locomotion, exploration and motivation, respectively [15] .
Tail suspension test. After evaluation in the open-field test, the TST was performed, in which a decrease in immobility time indicates antidepressant-like effect [16] . Immobility time was recorded for 6 min. Imipramine was used as positive control.
Comet assay. The animals were killed 24 hr after receiving the last dose of the subchronic treatment, and blood, liver and cerebral cortex tissue samples were collected to perform the alkaline comet assay as described by Tice et al. [17] with minor modifications. The images of 100 randomly selected cells (50 from each of two replicate slides) were analysed for each animal. The cells were scored visually according to tail size into five classes ranging from undamaged (0) to maximally damaged (4), resulting in a single DNA damage score for each animal and each group studied. The damage index (DI) ranged from 0 (completely undamaged, 100 cells 9 0) to 400 (maximum damage, 100 cells 9 4). The damage frequency (DF) was calculated based on number of cells with tails versus those without.
Micronucleus test. The micronucleus test was performed according to the US Environmental Protection Agency Gene-Tox Program guideline [18] . Bone marrow extracted from both femurs of mice 24 hr after the last dose of the subchronic treatment was suspended in foetal calf serum and smeared on clean glass slides. The slides were air-dried, fixed in methanol, stained in 10% Giemsa and then coded for a blind analysis. To avoid false-negative results and obtain a measure of bone marrow toxicity, the polychromatic erythrocytes: normochromatic erythrocytes (PCE:NCE) ratio was scored in 1,000 cells. The incidence of micronucleus (MN) formation was determined in 2000 PCE for each animal.
Statistical analysis. The behavioural tests were evaluated using the one-way analysis of variance (ANOVA), followed by Duncan's (post hoc) test. Data were presented as mean AE standard error of the mean (S.E.M.). The data from the comet assay and the micronucleus test were expressed as mean AE standard deviation (S.D.), and the statistical evaluation was carried out using an ANOVA complemented by Dunnett's test. For all comparisons, p ≤ 0.05 indicated statistical significance.
Results and Discussion
Platonia insignis Mart. is a plant widely used in the Amazon region as food and in folk medicine [19] . However, there is little scientific evidence of its pharmacological properties and the safety of using this plant or its components. This study assessed the toxicological and neuropharmacological parameters of GFC, a polyisoprenylated benzophenone isolated from P. insignis seeds. The purity of GFC was determined to be 96% by HPLC ( fig. 1 ) and 1 
HNMR.
The neurotoxicity of GFC was evaluated after subchronic treatment using the rotarod test ( fig. 2 ). There was no significant difference between the groups (p = 0.232), suggesting that the doses of GFC tested did not induce neurological effects on motor co-ordination or muscle relaxation. Da Silva et al. [10] showed that acute treatment with GFC 25, 50 and 75 mg/kg did not affect motor co-ordination. Also, Mohanasundari et al. [20] demonstrated that the performance of mice treated with the ethanolic extract of H. perforatum, a species rich in hyperforin that is structurally similar to GFC, was not impaired in the rotarod test.
The results of the subchronic treatment with GFC in the open-field test ( fig. 3) were not significantly different from those exhibited by the control group in the parameters latency to start locomotion (p = 0.084), crossings (p = 0.067) or number of rearings (p = 0.338). These data suggest that GFC has no effect on the motivation, exploration and locomotion of mice when administered at the doses tested. Previous evaluations of fractions of Platonia insignis have been reported. In rats, the ethyl acetate fraction of the seeds of Platonia insignis (10 mg/kg) did not affect ambulation and rearing parameters [21] . Moreover, similar to our results for GFC, hyperforin (0.1-0.38 mg/kg, i.p) did not change locomotion parameters in rats, compared to the control group in an experiment conducted by Cervo et al. [22] . Recently, a study reported that acute treatment with GFC produced no change in locomotor activity in mice [10] . Our experiments revealed that GFC did not influence the results of the open-field model after 28 days of treatment, indicating that this compound was not able to alter locomotor and exploratory activity of the animals even after subchronic treatment.
Because of the recognized antidepressant effect of hyperforin and its similarity in chemical structure with GFC, we decided to evaluate a possible antidepressant effect of GFC. The antidepressant potential of hyperforin has already been reported using the TST and forced swim test (FST) behavioural models. The doses ranged from 0.19 to 20 mg/kg for rats and 4 to 8 mg/kg for mice [22] [23] [24] . Hyperforin is known to reduce the reuptake of serotonin and norepinephrine, thereby increasing the levels of these neurotransmitters, which are low in depression scenarios [25] . Here, we evaluated the antidepressant effect of GFC (2, 10 and 20 mg/kg) after repetitive doses (for a 28-day period) in the TST, an important predictive model of antidepressant activity [16] . The results showed that GFC did not affect immobility time measured in this task after subchronic treatment, differently from imipramine, which was used as positive control (fig. 4) . These data suggest that the GFC doses used did not have any antidepressant-like activity in the TST.
The possible genotoxic effect of GFC was evaluated using blood, liver and cerebral cortex samples in the comet assay (table 1). This assay is used to detect genotoxic effects measured as DNA damage such as single-and double-strand breaks, alkali-labile sites, and DNA-DNA and DNA-protein crosslinks [17] ; it has become an important tool to detect DNA damage in specific tissues and complement the mutagenic assays during the research and development of new substances with pharmacological potential [26] . Garcinielliptone FC did not have genotoxic effects on blood and cerebral cortex, confirming the lack of systemic toxicity when administered as lower doses. The lack of genotoxic effects in the cerebral cortex is in agreement with the results of the behavioural tests, where GFC did not impair motor co-ordination or muscular relaxation in the rotarod test or overall locomotion in the open-field assay. However, GFC 20 mg/kg induced DNA damage in the liver (significant increase in DI and DF). In HepG2 cells, the comet assay showed that GFC did not induce DNA damage [11] , which was attributed to the high capacity of those cells to metabolize xenobiotics due to the presence of several phase I and phase II enzymes. Here, intraperitoneal administration of GFC was not able to induce DNA damage in blood and cerebral cortex, but DNA damage was observed in liver, suggesting hepatic overload caused by accumulation of repetitive administrations of GFC. As already mentioned, GFC is a benzophenone, and toxic effects have been attributed to this group of compounds. In repeated-dose studies, degenerative effects were observed in the liver of rats, suggesting that the organ may be the primary target of benzophenone toxicity [27] . In the study published by Burdock et al. [28] , benzophenones were administered to rats in their diet as a 20 mg/kg/day dose for 90 days and 100 or 500 mg/ kg/day doses for 28 days. Both absolute and relative liver weights increased, and histopathology showed hepatocellular enlargement with an associated clumping of cytoplasmic basophilic material around the central vein after administration of the intermediary and high doses. Nevertheless, oral treatment with GFC at 25, 50 and 75 mg/kg for 30, 90 and 120 days afforded a good margin of safety in experimental animals [9] . The micronucleus test was performed to detect clastogenic and aneugenic activities, which increase micronucleus frequency and suggest mutagenic effects at chromosomal level [18] . As shown in table 2, GFC did not increase micronucleus frequency in bone marrow. In our previous study, GFC significantly increased micronucleus frequency when administered at the highest dose tested in the CBMNCyt assay [11] , supporting further in vivo evaluations. The results of the present study showed that GFC is not able to induce mutagenesis in vivo. The PCE:NCE ratio was similar for all groups. Only the positive control (cyclophosphamide) showed a more significant increase in micronucleus frequency compared with the saline group. In the same way, benzophenone showed no genotoxic potential in in vitro and in vivo experimental assays [27] . A few studies have evaluated the effects of GFC on the CNS. Da Silva et al. [2] showed that GFC 25, 50 and 75 mg/kg p.o. increase latency of seizures in the mouse pilocarpine model. In addition, the authors showed that this effect was correlated with gamma-aminobutyric acid (GABA) modulation, glutamate contents and acetylcholine (AChE) activity. Another study suggested that the antioxidant activity of this compound is due to an increase in superoxide dismutase activity in the rat hippocampus [29] . Recently, it was demonstrated that GFC did not promote behavioural nor biochemical changes after acute treatment [10] .
In summary, despite exhibiting other CNS effects, GFC did not induce antidepressant-like responses in the TST model administered subchronically, and it had no effect on the motor performance, mobility and motivation of the animals in the present study. Garcinielliptone FC did not elicit mutagenic responses in bone marrow or genotoxicity in either cerebral cortex or blood after 28 days of treatment. The highest dose (20 mg/kg) induced DNA damage in the liver tissue, suggesting that this dose of GFC is hepatotoxic in subchronic treatments. Considering the toxicity profile of GFC reported here, where the compound showed low toxicity though with no behavioural impairment, further studies should be conducted to identify the possible biological applications of this compound.
